GANX 8-K: SEC filing
Filed with the SEC on · accession 0001104659-26-125159
GANX filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved -0.9% by the first close after the filing.
Summary of the filing
Gain Therapeutics, Inc. furnished a Form 8-K announcing its financial results for the third quarter ended September 30, 2026, along with a business update, via an attached press release.
Key details
How GANX stock reacted
Close before
$1.09
Nov 9, 2026
First close after
-0.92%
$1.08
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for GANX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for GANX?
Click hereFrequently asked questions
What did GANX file with the SEC on Nov 10, 2026?
GANX filed a 8-K (SEC filing). Gain Therapeutics, Inc. furnished a Form 8-K announcing its financial results for the third quarter ended September 30, 2026, along with a business update, via an attached press release.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did GANX stock react to this filing?
GANX closed at $1.09 before the filing and $1.08 on Nov 10, 2026 (-0.92%).
Other GANX SEC filings
Get alerts when GANX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days